Purpose: We compared the timing, causes, hospital costs and perioperative outcomes of index vs nonindex hospital readmissions after radical cystectomy. Materials and Methods: The 2013 Nationwide Readmissions Database was queried for patients with bladder cancer undergoing cystectomy. Sociodemographic characteristics, hospital costs and causes of readmission were compared among index and nonindex readmitted patients. Univariable and multivariable logistic regression models were used to identify predictors of nonindex readmissions, mortality during the first readmission and subsequent readmission. Results: Among 4,991 patients identified 29% (1,447) and 11% (571) experienced an index and nonindex readmission, respectively. Compared to index readmissions, nonindex readmissions were more likely late readmissions (p <0.001) of older patients (p¼0.047) who underwent cystectomy at higher volume hospitals (p¼0.02) and were readmitted to hospitals located in less populated areas (p <0.001). Compared to index readmissions the percentage of nonindex readmissions for cardiovascular complications was higher (7.6% vs 2.9%, p¼0.003), while the percentage of nonindex readmissions for gastrointestinal (6.0% vs 11.0%, p¼0.04) and wound (5.3% vs 16.7%, p¼0.0001) complications was lower. Predictors of nonindex readmission included longer length of stay (OR 1.02; 95% CI 1.001, 1.04), patient location in less populated areas, nonteaching hospital (OR 0.52; 95% CI 0.31, 0.86) and discharge to facility (OR 2.82; 95% CI 1.75, 4.55) or with home health (OR 1.49; 95% CI 1.05, 2.10). Nonindex readmissions had comparable mean readmission hospital costs ($14,147 vs $15,102, p¼0.7), inhospital mortality (OR 1.11; 95% CI 0.42, 2.87) and subsequent readmission (OR 1.32; 95% CI 0.87, 2.00) to index readmissions. Conclusions: This nationally representative study of patients undergoing radical cystectomy demonstrated comparable perioperative outcomes and hospital costs between index and nonindex readmitted patients, which supports the continued regionalization of cystectomy care.
THE gold standard treatment for muscle invasive bladder cancer is radical cystectomy with pelvic lymph node dissection. Numerous studies have demonstrated high perioperative complication and hospital readmission rates after RC, ranging from 19% to 64% and 25% to 41%,
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The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number. respectively. 1e5 The urological community has focused on identifying methods to improve perioperative outcomes for patients undergoing RC, and much of this focus has been on the regionalization (or centralization) of RC to tertiary care centers. 6e8 While regionalization of treatment to high volume centers and surgeons is associated with improved perioperative survival, there are also associated harms. Regionalization results in increased travel distances for patients to receive care, which is associated with increased rates of care fragmentation defined by nonindex readmissions. 4,7,9e12 A nonindex readmission is a readmission to a hospital where the initial procedure was not performed. Several studies in surgical populations have shown that care fragmentation is associated with worse short and long-term outcomes such as increased in-hospital mortality, longer length of stay during readmission, higher 90-day post-readmission mortality, subsequent readmissions, increased cost of readmission and 1-year mortality. Therefore, we compared the causes of index and nonindex hospital readmissions to determine patient and hospital level predictors of nonindex readmissions and to investigate the effect of nonindex hospital readmissions on perioperative outcomes in a contemporary, nationally representative database of patients treated with RC in the United States.
METHODS
Data Source
The Nationwide Readmissions Database is a stratified, single stage clustered sample of hospital discharges created from 21 State Inpatient Databases by the Healthcare Cost Utilization Project, Agency for Healthcare Research and Quality. 19 The database provides hospital and patient identification numbers to track inpatient encounters for an individual throughout hospitals across the state.
Patient Cohort
With Johns Hopkins Medical Institution institutional review board approval the 2013 NRD was queried using ICD-9 codes to identify patients with bladder cancer (188.x, 233.7) undergoing cystectomy (57.71, 57.79). Patients with metastatic disease (19.7x, 19.8x ) and who died during the initial hospitalization were excluded from analysis. Additionally, nonresidents of the state in which the RC was performed were excluded, as they would be more likely to be readmitted in their home state, which would not be captured in the NRD. Patients discharged after October were excluded to ensure all individuals would have 90-day followup in the NRD.
Index and Nonindex Readmissions
Index readmissions were defined as readmissions to the same hospital where RC was performed while nonindex readmissions were defined as readmissions to a different hospital. Readmissions with a transfer from a nonindex to index hospital were defined as nonindex readmissions since the patient initially presented to the nonindex hospital. 15 
Early and Late Readmissions
Early and late readmissions were defined as readmissions occurring 30 days or less and 31 to 90 days after discharge from the initial hospitalization, respectively. 3 For patients with multiple readmissions only the first readmission was used for analyses. We graphed the proportion of index and nonindex readmissions occurring on each day in the followup period with a moving average of 4 days, which is an average of that day and the next 3 days to allow easier visualization of data trends.
Sociodemographic and Hospital Variables
Patient and hospital level exposure variables included age, gender, primary payer, median household income national quartile for patient home zip code, initial hospitalization length of stay, hospital location, hospital teaching status, hospital bed size and initial hospitalization patient discharge disposition. Hospital procedure volume was categorized as low (1 to 8 cystectomies), intermediate (9 to 30 cystectomies) or high (31 or more cystectomies), so that when weighted, a similar percentage of RCs would be in each category. 20 Using a previously validated algorithm a Charlson comorbidity index score was calculated for each patient using ICD-9 codes from the initial hospital discharge. 21 This was modified to exclude points attributable to cancer diagnoses as all patients in this cohort had cancer diagnoses.
Surgical and Complication Variables
The surgical approach was assumed to be open unless ICD-9 codes indicated a minimally invasive surgical approach (54.21, 54.51, 17.4x). 22 Urinary diversion was categorized as an ileal conduit (56.51, 56.71), continent diversion (57.87) or unknown. Complications during the initial hospitalization were identified with ICD-9 codes (supplementary table 1, http://jurology.com/).
Causes of Readmission
The cause of readmission was determined by the principal ICD-9 diagnosis code for each readmission (supplementary table 2, http://jurology.com/). 23 
Outcomes after Readmission
The 2 outcomes investigated after readmission were mortality during the readmission and subsequent readmission during the 90-day followup period, as these were used by previous studies.
12,15
Cost Outcomes
Charges were converted into costs using hospital specific cost-to-charge ratios provided by the NRD. Inpatient hospital costs were calculated for the initial hospitalization, readmission, and 30 and 90-day followup.
Statistical Analysis
Sociodemographic variables, hospital level variables, causes of readmission and costs were compared among index vs nonindex readmissions using the Student t-test, chi-square test and linear regression, as appropriate. Costs were compared using log transformation with gamma distribution modeling to account for the skewness of cost data. 24 Univariable and multivariable logistic regression models were used to determine predictors of nonindex readmissions, index readmissions, mortality during the first readmission and subsequent readmission. For the nonindex and index readmission multivariable multinomial logistic regression, a sensitivity analysis was conducted treating the hospital volume variable as a continuous variable. The qualitative results were comparable, with the same variables maintaining statistical significance, so those results are not presented. For all analyses sample weights were used to create nationally representative estimates with the hospital as the sampling unit. All analyses were conducted using StataÒ version 14. All reported p values were 2 sided and p 0.05 was considered statistically significant for all tests.
RESULTS
When weighted, 4,991 patients underwent cystectomy for bladder cancer. Of these patients 29% (1,447) had an index hospital readmission and 11% (571) had a nonindex readmission. Approximately 3% (64 of 2,018) of readmitted patients were transferred from a nonindex to an index hospital. Comparisons of baseline patient level, hospital level and hospital costs for index and nonindex readmission are listed in supplementary table 3 (http://jurology. com/) and table 1. Nonindex readmissions were more likely than index readmissions to be late readmissions (p <0.001) of older patients (p¼0.047) who had RC performed at higher RC volume hospitals (p¼0.02), and were more likely to occur at hospitals located in less populated areas (p <0.001). Of note, there was no difference between index and nonindex readmissions in length of stay (p¼0.6) of the readmission, cost (p¼0.7) of the readmission, and followup costs at 30 (p¼0.9) and 90 (p¼0.9) days.
Timing of First Readmission
The proportion of index and nonindex readmissions by days after discharge from initial hospitalization is shown in the figure. Of note, a higher proportion of nonindex readmissions occurred in the late period compared to index readmissions, especially in the 30 to 50-day followup period. Of note, discharge to facility was also associated with index readmissions, while a longer length of stay and residence in less populated areas were associated with lower odds of index readmission.
Causes of Readmission
Predictors of Mortality during First Readmission
No predictors of mortality during the first readmission were identified in univariable and multivariable logistic regression models (supplementary  table 5 , http://jurology.com/).
Predictors of Second Readmission
Univariable and multivariable logistic models to identify predictors of a second readmission are listed in supplementary table 6 (http://jurology.com/). On univariable analysis index readmission was associated with increased odds of subsequent readmission (OR 1.42; 95% CI 1.02, 1.98; p¼0.04), but after controlling for the timing of the first readmission (early vs late) the association between index readmission and subsequent readmission was not significant in the nested (OR 1.24; 95% CI 0.89, 1.73; p¼0.2) and full (OR 1.32; 95% CI 0.87, 2.00; p¼0.2) multivariable models.
DISCUSSION
To our knowledge this is the first study in a nationally representative database investigating the timing, causes and importance of index and nonindex readmissions on short-term outcomes in patients treated with RC. Consistent with previous studies, nonindex readmissions were more likely than index readmissions to be late readmissions (31 to 90 days after initial discharge) and from higher RC volume centers (31 or more cystectomies).
3,9,15
Overall 28% (571 of 2,018) of readmissions occurred at nonindex hospitals, raising concern for care fragmentation. Specifically, the association of higher RC volume hospitals with increased nonindex readmissions highlights one of the concerns associated with the regionalization of RC. As regionalization occurs the rate of care fragmentation increases, which previous studies have demonstrated can lead to worse perioperative outcomes such as increased in-hospital mortality, longer length of stay during readmission, higher 90-day post-readmission mortality, subsequent readmissions, increased cost of readmission and increased length of stay on readmission. However, in the current study all of the cost and outcome metrics were comparable between patients who were readmitted to index vs nonindex hospitals. This finding suggests that patients traveling long distances to undergo RC at centers of excellence would likely prefer to be readmitted locally, since our results demonstrate that the costs and outcomes associated with nonindex readmission are comparable to readmission at the index hospital. Future studies are warranted to investigate patient and hospital level characteristics that can be used to identify specific patients for whom a nonindex readmission may be associated with more harm than an index readmission. In this study the comparable in-hospital mortality between index and nonindex readmitted patients is consistent with that of a previous study conducted by Pak et al in patients treated with RC, while the comparable rate of subsequent readmissions, cost of readmission and readmission length of stay were not consistent. 15 This discrepancy could be related to differences in the patient cohort, as Pak et al used a data set of only New York State patients, while this study was conducted in a nationally representative data set of 21 states that was specifically designed to address these types of hypotheses.
In this study we demonstrated that controlling for the timing of the first readmission is important when determining predictors of subsequent readmission, as the association between index readmissions and increased odds of subsequent readmission was no longer present when the timing of the readmission was included in the models. Therefore, as readmissions continue to be an important quality of care metric, it is imperative for studies to take into account the timing (early vs late) and location (index vs nonindex) of readmissions in their analyses.
Of note, predictors of nonindex hospital readmission included longer initial hospitalization length of stay, patient residence in less populated location, patient residence in higher income area and discharge with home health or to a facility. It is likely that the increased odds of nonindex readmission among patients with residences in less populated areas is due to increased travel distance to the index hospital for these patients, as it has been previously demonstrated that increased travel distance is associated with nonindex readmissions. 4 This explanation is further supported by the fact that compared to index readmissions, nonindex Proportion of index and nonindex readmissions for each day after initial hospital discharge during 90-day followup readmissions were more likely to occur at nonmetropolitan hospitals. These hospitals are likely closer to patients residing in rural areas who would have to travel a long distance to their index hospital. It is also possible the effect of length of stay of the initial hospitalization is mediated by travel distance, as patients who travel longer distances have been shown to have longer initial hospital length of stays in other surgical cohorts. 25, 26 Transfer to a facility was associated with index and nonindex readmissions, which suggests these patients are overall at higher risk for readmission, which is consistent with previous studies. 27 Of note, diversion type, which has previously been associated with readmission, was not associated with index or nonindex readmission in this study. 28 Regionalization of RC occurred as a natural byproduct of the high perioperative burden associated with the procedure. From a clinical standpoint the practice of referring RC cases to high volume, tertiary care centers should continue. Even though patients who are referred may have longer travel distances that predispose them to a higher risk of care fragmentation, our findings suggest there are comparable costs and no perioperative harms associated with nonindex vs index readmissions. Moreover, as new technologies such as telemedicine and regional online medical record exchange are adopted, there is an increased potential for continuity of care and improved health care at nonindex hospitals with mitigation of the harmful effects of care fragmentation, especially for patients residing in rural areas far from their index hospital. From a payer's perspective these findings suggest that regionalization of RC to high volume, tertiary care centers with followup care at local hospitals is in fact a viable model with comparable hospital costs and short-term perioperative outcomes. Of note, we were unable to evaluate differences in outpatient health care costs, but hospital costs represent the overwhelming majority of perioperative costs associated with RC. 29 From the patient's perspective the effect of index vs nonindex readmissions on long-term health related quality of life is currently unknown and future studies to investigate the potential association are warranted. Moreover, as more institutions continue to adopt enhanced recovery after surgery protocols for patients undergoing cystectomy, the effect of these protocols on readmission rates and causes of readmission warrants investigation. Additionally, future research efforts should focus on examining potential differences in 1 to 2-year survival between index and nonindex readmitted RC cases as previous studies in gastrectomy and urinary diversion have demonstrated survival differences at the 1 or 2-year postoperative point based on readmission location. 14, 17 This study has limitations that should be acknowledged. Due to the nature of the database there is no information on travel distance from patient residence to the nearest hospital or index hospital, neoadjuvant chemotherapy or bladder cancer staging, so these variables could not be controlled for. However, previous studies have reported no difference on perioperative morbidity and mortality with neoadjuvant chemotherapy. 30 Additionally, this study excluded patients with metastatic disease, and since patients in this study were undergoing RC, the majority of patients in this cohort likely had clinically staged muscle invasive disease. This study only included patients who were residents of the state in which they underwent RC so that readmissions would be captured more accurately. Therefore, these results should not be extrapolated to patients who are nonresidents of the state in which their RC is performed. Moreover, the only mortality data provided are in-hospital mortality. Deaths occurring after discharge from the readmission in settings outside of the hospital are not captured. As a result, we are not able to evaluate the effect of nonindex readmissions on survival at later points.
CONCLUSIONS
This nationally representative study of patients treated with RC suggests that index and nonindex readmissions are associated with comparable perioperative outcomes and hospital costs. The inability to demonstrate an association of increased costs or harms with nonindex readmissions compared to index readmissions provides support for the regionalization of RC.
